Ratification of pre-clinical methodology for evaluating the effectiveness of cosmetic products in the protection against the harmful effects of infrared radiation

• Grant number: 19/19738-6
• Support Opportunities: Research Grants - Innovative Research in Small Business - PIPE
• Start date: December 01, 2020
• End date: January 31, 2023
• Field of knowledge: Biological Sciences - Pharmacology
• Principal Investigator: Gustavo Facchini
• Grantee: Gustavo Facchini
• Company: Kosmoscience Consultoria e Assessoria Técnica em Cosméticos Ltda (KosmoScience)
• CNAE: Pesquisa e desenvolvimento experimental em ciências físicas e naturais ; Atividades profissionais, científicas e técnicas não especificadas anteriormente
• City: Valinhos
• Associated research grant: 15/08598-8 - Determination of the effect of infrared-A radiation on gene modulation in human skin culture to develop an alternative method for assessment of preclinical efficacy, AP.PIPE

Abstract

Brazil occupies the fourth place in the ranking of consumption of cosmetic products and presents a recovery of the growth rate concerning the first place - USA, China and Japan. Regarding this economic context, we can consider that the trajectory of the Brazilian cosmetic market is considered dynamic on the international scene. According to ABIHPEC*, approximately 15% of the annual total of this market, which reached US$ 30 billion in 2018, is intended for research, development, and communication of new products and launches. In this way, the search for safest and more effective ingredients and products reinforces the need to elaborate refined methodologies that better translates its effects. The advent of the 3R policy (Replace, Reduce and Refine) that supports the use of alternative tests to replace, refine and reduce the use of animals in research, safety assessment and cosmetic efficacy were restricted to in vitro and clinical models. In vitro assays can predict possible toxic effects and determine the likely biological mechanisms of action responsible for the clinical benefit of cosmetic, complementing the results in vivo, although the direct inference from these results requires caution, because not always the mechanisms observed in cell cultures can be extrapolated to the real condition of use. Similarly, clinical outcomes, although providing a strong contribution to the assessment of safety and efficacy cosmetic, do not provide data related to the mechanisms of action, such as those obtained by in vitro techniques. Thus, a plausible and sustainable alternative to fill this gap between in vitro and clinician is using skin equivalent or skin fragments from elective surgeries, which are characterized as ex vivo model to approach the real responsible purpose by clinical benefits of a product applied topically. Clinical signs of photoaging skin such as wrinkles and hyperpigmentation are among the main aesthetic concerns that affect humans. Proven ultraviolet radiation is the main factor that contributes to tissue damage and skin aging, however, the infrared radiation A (IV-A) has been identified as an aggravating of this process, corroborating the physiological skin changes. Given these considerations, the objective of this study is to evaluate the effects of IVA radiation on the modulation of large-scale gene expression using as substrate the spare human skin fragments of elective plastic surgery to develop and make available an alternative assessment methodology of preclinical efficacy. (AU)